Join to View Full Profile
200 Cabrini Blvd APT 115New York, NY 10033
Phone+1 212-305-4637
Fax+1 212-305-1295
Dr. Szabolcs is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1990 - 1994
University of Vienna Faculty of MedicineClass of 1989
Certifications & Licensure
NY State Medical License 1997 - 2027
PA State Medical License 1993 - 2016
MN State Medical License 1998 - 2000
American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 1 citationsDominant intragraft plasma cells targeting bilirubin implicate local heme catabolism in human cardiac allograft vasculopathy.Sarah B See, Talita Aguiar, Max Dietzel, Mattea Ausmeier, Hang Tt Nguyen
The Journal of Clinical Investigation. 2026-02-02 - 7 citationsNew standards in HER2-low testing: the CASI-01 comparative methods study.David J Dabbs, Emina Torlakovic, Søren Nielsen, Suzanne C Parry, Jing Yu
Ebiomedicine. 2025-10-01 - 1 citationsBiallelic potential disease-causing missense variants in TAF1A in two siblings with infantile restrictive cardiomyopathy.Nan Jiang, Wenyuan Xu, Aliaa Abdelhakim, Anastasiya Matveyenko, Matthias Szabolcs
European Journal of Medical Genetics. 2024-10-01
Journal Articles
- Article the BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork ProtectionMatthias Szabolcs, MD, ScienceDirect
- Mouse ER+/PIK3CAH1047R Breast Cancers Caused by Exogenous Estrogen Are Heterogeneously Dependent on Estrogen and Undergo BIM-Dependent Apoptosis with BH3 and PI3K AgentsMatthias Szabolcs, Ramon Parsons, Hank Schmidt, Nature
Press Mentions
Boston Cell Standards Wins FDA $510K Clearance for Anatomic Pathology ControlsOctober 12th, 2022- FLT1 Activation in Cancer Cells Promotes PARP-Inhibitor Resistance in Breast CancerJuly 8th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
